Refills review

Refills offers a convenient way to compare several prescription categories from one account, and it is more specific about its dispensing and clinical partners than many small telehealth brands. Its public pharmacy page names Perfect Rx and Hallandale; the platform also identifies independent clinician networks. The homepage promises no membership or app fees and says dose changes do not increase the price. However, its $5-per-day GLP-1 headline and promotional banners do not provide a dependable renewal total for a specific drug and supply. Treatment is a subscription even though there is no separate membership charge. Its legal terms require cancellation at least 72 hours before processing, which is more important than the shorter cancel-anytime slogan. Refills makes sense for someone who values one portal and disclosed partners, provided the written order shows the renewal charge, quantity, actual pharmacy and cancellation deadline.

Refills Health is a technology and administrative platform, not the medical practice or pharmacy. Its disclaimer names partners such as Beluga Health, Bask Health, Wasef Health and TelegraMD, with prescribing decisions made independently by clinicians. Its pharmacy partner page lists PerfectRx LLC in Bartonville, Texas, and Hallandale Pharmacy, operated as Pharmcore, Inc., in Fort Lauderdale, Florida. The broader terms allow other pharmacies, including Greenwich Pharmacy, VialsRx and The Pharmacy Hub. That means a published partner list is useful transparency but does not guarantee a particular pharmacy will dispense every product. The catalog includes personalized GLP-1 and GIP-plus-GLP-1 injections, sildenafil and tadalafil, NAD+ and sermorelin injections, and hair-loss treatments. The service says no insurance is required. It is best understood as access to independently delivered prescription care rather than a single in-house clinician-and-pharmacy operation.

Patients choose a treatment category and complete a health assessment. A licensed clinician reviews the information, determines whether treatment is suitable, and issues a prescription only if appropriate. The initial assessment alone does not create a clinician-patient relationship with Refills, according to the platform’s disclaimer. Once approved, the subscription starts automatically; medication is dispensed through a pharmacy partner and shipped discreetly. The FAQ describes typical arrival in three to five business days after approval and pharmacy processing, which is not a guarantee from the moment a patient begins the quiz. Support is available through the account, and Refills advertises a health concierge available around the clock. Concierge access should not be confused with an immediate physician appointment. Ask how to contact the prescriber about side effects, how refill reviews occur, and which questions require another clinical visit. For someone ordering more than one treatment category, ask whether the same clinician can review the whole medication list.

The homepage advertises GLP-1s from $5 per day and displays new-patient promotional discounts, but those figures do not settle the monthly renewal cost, included quantity or commitment for every product. It says there are no separate monthly membership or app fees, that prescription care and shipping are included, and that dose changes do not alter the price. The actual selected plan and checkout agreement should confirm the drug, formulation, supply, promotion duration and ongoing charge before payment. Refills’ terms describe a combined price covering the prescription drug, professional services and platform services; lack of a membership fee does not mean those services have no cost. The FAQ allows pausing, skipping or canceling through the dashboard, while the terms require action at least 72 hours before the applicable processing date, either through the account or support. A patient close to renewal should follow that more specific cutoff. State coverage also needs confirmation: the homepage says all 50 states but excludes the District of Columbia, the terms include D.C., and the FAQ says most states with product-dependent availability. We do not turn that conflict into a nationwide guarantee.

The website labels the weight-loss injections as personalized GLP-1 and personalized GIP-plus-GLP-1 products rather than promising a branded pen. The FAQ discusses GLP-1-only options, including semaglutide-based or liraglutide-based treatment, and dual-pathway options; the prescriber and dispensing label must identify the actual ingredient and concentration. Refills explicitly says its compounded drugs are not FDA-approved and have not been evaluated by the agency for safety, effectiveness or quality. The fact that a pharmacy is licensed and inspected does not transfer the clinical-trial results of an approved brand to the compounded product. The wider catalog includes sildenafil and tadalafil for erectile dysfunction, plus NAD+ and sermorelin injections marketed under daily health. Those are distinct clinical decisions. Combining them in one online shop is an administrative convenience, not evidence that every patient should use them together or that longevity claims have been established. Obtain a treatment-specific explanation of expected benefit, monitoring and risks from the clinician.